TTALO logo

Terveystalo Oyj Stock Price

HLSE:TTALO Community·€949.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

TTALO Share Price Performance

€7.49
-3.17 (-29.74%)
€9.20
Fair Value
€7.49
-3.17 (-29.74%)
18.6% undervalued intrinsic discount
€9.20
Fair Value
Price €7.49
AnalystConsensusTarget €9.20
AnalystLowTarget €7.90
AnalystHighTarget €10.50

TTALO Community Narratives

·
Fair Value €9.2 18.6% undervalued intrinsic discount

Earnings Will Grow Faster In 2025 With Improved Margin Outlook

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value €7.9 5.2% undervalued intrinsic discount

Digital Efficiency Gains And Senior Care Demand Will Support A Steady Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €10.5 28.7% undervalued intrinsic discount

Digital Healthcare And Senior Services Will Reshape This Undervalued Nordic Provider

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€9.2
18.6% undervalued intrinsic discount
Revenue
4% p.a.
Profit Margin
8.29%
Future PE
12.2x
Price in 2029
€11.09
€7.9
5.2% undervalued intrinsic discount
Revenue
0.93% p.a.
Profit Margin
8.2%
Future PE
11.58x
Price in 2029
€9.51

Trending Discussion

No trending discussion available.

Updated Narratives

TTALO logo

TTALO: Higher Revenue Outlook And Meeting Agenda Will Support Future Upside

Fair Value: €10.5 28.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TTALO logo

TTALO: Lower Profitability Outlook Will Still Support Long-Term Upside Potential

Fair Value: €9.2 18.6% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TTALO logo

Digital Efficiency Gains And Senior Care Demand Will Support A Steady Outlook

Fair Value: €7.9 5.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued second-rate dividend payer.

2 Risks
3 Rewards

Terveystalo Oyj Key Details

€1.2b

Revenue

€873.0m

Cost of Revenue

€338.9m

Gross Profit

€271.0m

Other Expenses

€67.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 23, 2026
0.54
27.96%
5.60%
85.4%
View Full Analysis

About TTALO

Founded
2001
Employees
7698
CEO
Ville Iho
WebsiteView website
www.terveystalo.com

Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral health, social, ER, well-being, and primary healthcare and specialty care services, as well as imaging and laboratory tests. It also provides remote and digital, diagnostic and screening, therapy and rehabilitation, and occupational health; leasing of personnel, partnership solutions, and assessment of the need for care; and organizational management consulting and addiction prevention services. The company serves private individuals and families, corporate and consumer, insurance companies, and public sector customers. Terveystalo Oyj was founded in 2001 and is headquartered in Helsinki, Finland.

Recent TTALO News & Updates

Analysis Article Jul 22

Terveystalo Oyj Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next

As you might know, Terveystalo Oyj ( HEL:TTALO ) last week released its latest second-quarter, and things did not turn...
Narrative Update Jul 08

TTALO: Higher Revenue Outlook And Meeting Agenda Will Support Future Upside

Analysts have reduced their fair value estimate for Terveystalo Oyj from €11.50 to €10.50, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples. What's in the News for Terveystalo Oyj Terveystalo Oyj has scheduled a Special and Extraordinary Shareholders Meeting for June 30, 2026, at 14:30 FLE Standard Time.

Recent updates

No updates